摘要
胶质瘤是成人最常见原发性脑肿瘤,年发病率大约在4~5/10000…。对高级别胶质瘤治疗效果的评价目前主要依据患者生存时间,或是无进展生存时间及影像学缓解率,后者在复发病变中更常用。90年代初Macdonald等。提出了高级别胶质瘤治疗反应的判定标准。
出处
《中华神经外科杂志》
CSCD
北大核心
2013年第11期1180-1182,共3页
Chinese Journal of Neurosurgery
基金
国家自然科学基金(81302200)
参考文献4
-
1中国中枢神经系统恶性胶质瘤诊断和治疗共识(简化版)[J].中华医学杂志,2009,89(43):3028-3030. 被引量:50
-
2陈宝师,张伟,李守巍,张忠,江涛.抗血管生成靶向药物治疗恶性胶质瘤的临床研究[J].中国现代神经疾病杂志,2008,8(5):432-436. 被引量:3
-
3杨学军,江涛,陈忠平,漆松涛.脑胶质瘤的规范化和个体化治疗与临床实践[J].中国神经精神疾病杂志,2009,35(6):321-322. 被引量:9
-
4JIANG Tao,TANG Gen-fu,LIN Yi,PENG Xiao-xia,ZHANG Xiao,ZHAI Xiu-wei,PENG Xiang,YANG Jin-qing,HUANG Hong-er,WU Nai-feng,CHEN Xiao-jun,XING Hou-xun,SU Tong-yong,WANG Zhong-cheng.Prevalence estimates for primary brain tumors in China: a multi-center cross-sectional study[J].Chinese Medical Journal,2011(17):2578-2583. 被引量:40
二级参考文献40
-
1Shai RM, Reichardt JK, Chen TC. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas[ J]. Future Oncol, 2008,4(4) :525 - 534.
-
2Sanson M. Editorial review: targets for glioma treatment: from bench to bedside [ J ]. Curr Opin Oncol, 2008, 20 (6) : 650 - 651.
-
3Sorensen AG, Batchelor TT, Wen PY, et al. Response criteria for glioma[J]. Nat Clin Pract Oncol, 2008, 5(11) :634-644.
-
4Brandsma D, de Bruin HG, Bromberg JE, et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide [ J ]. Cancer, 2008, 113(2) :405 -410.
-
5[1]American Cancer Society,American Society.Cancer Facts and Figures 2005.Atlanta:American Cancer Society,2005:1-64.
-
6[2]Central Brain Tumor Resistry of the United States(2005),Statistical Report:Primary Brain Tumors in the United States.1998-2002.Hinsdale:Central Brain Tumor Registry of the United States.2005:1-15.
-
7[3]Takano S,Yoshii Y,Kondo S,et al.Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients.Cancer Res,1996,56:2185-2190.
-
8[4]Abdulrauf SI,Edvardsen K,Ho K L.et al.Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.J Neurosurg,1998,88:513-520.
-
9[7]Willett CG,Boucher Y.di Tomaso E,et al.Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.Nat Med,2004,10:145-147.
-
10[8]Stupp R,Mason WP,van den Bent MJ,et al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med,2005,352:987-996.
共引文献98
-
1Zheng Zhao,Ke-Nan Zhang,Qiangwei Wang,Guanzhang Li,Fan Zeng,Ying Zhang,Fan Wu,Ruichao Chai,Zheng Wang,Chuanbao Zhang,Wei Zhang,Zhaoshi Bao,Tao Jiang.Chinese Glioma Genome Atlas(CGGA):A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients[J].Genomics, Proteomics & Bioinformatics,2021,19(1):1-12. 被引量:41
-
2李鲁,郑志明,许加军,王国栋,张永超,吴洪喜.经鼻蝶垂体瘤切除术后术区出血的临床分析[J].世界最新医学信息文摘,2020(10):77-78.
-
3张俊平,魏大年,史泓浏,岳伟英,于春江,陈忠平.体外药敏试验及化疗耐药和敏感分子特征指导的恶性脑胶质瘤临床个体化化疗研究[J].中国神经精神疾病杂志,2009,35(8):476-480. 被引量:7
-
4姚瑜,毛颖,周良辅.规范脑恶性胶质瘤治疗的几点建议——有感于《中国中枢神经系统恶性胶质瘤诊断和治疗共识(简化版)》[J].中华医学杂志,2010,90(15):1079-1080. 被引量:4
-
5涂媛,高俊,张尚福,苏学英.伴印戒细胞样细胞分化的中枢神经系统胶质母细胞瘤:病例报告及文献复习[J].中国现代神经疾病杂志,2010,10(5):572-577. 被引量:2
-
6李智奇,张义.弥散张量成像在脑胶质瘤中的应用[J].中国神经精神疾病杂志,2011,37(4):252-254. 被引量:3
-
7杨学军.中枢神经系统肿瘤转化医学是理念更是实践[J].中华神经医学杂志,2011,10(6):541-543.
-
8韩明,袁芳,董丽萍,师忠芳,袁辉,杨少华.人脑多形性胶质瘤细胞系BT325对5种抗肿瘤药物敏感性的研究[J].中国康复理论与实践,2011,17(9):840-843.
-
9李志勇,漆松涛,陈龙华,丁彦青.南方脑胶质瘤中心胶质瘤治疗路径[J].中国微侵袭神经外科杂志,2011,16(10):433-436. 被引量:17
-
10徐国政,杜浩,高宝成,张新元,文雪,宋健,黄河,袁先厚.恶性脑胶质瘤预后相关多因素分析[J].中华神经外科杂志,2011,27(10):1040-1044. 被引量:10
同被引文献59
-
1王凤玮,温玲,朱思伟,姚嫱,蔡玉梅,马刚.结直肠癌组织中突变型Axin2对Wnt信号转导系统的调控及其机制[J].癌症,2007,26(10):1041-1046. 被引量:9
-
2Reardon DA, Galanis E, DeGroot JF, et ol. Clinical trial end points for high-grade glioma: the evolving landscape [J]. Neuro Oncol, 2011, 13(3): 353-361.
-
3Chinot OL, Macdonald DR, Abrey LE, et ol. Response assessment criteria for glioblastoma: practical adaptatior and implementation in clinical trials of antiangiogenic therapy [J]. Curr Neurol Neurosci Rep, 2013, 13(5): 347.
-
4Wen PY, Norden AD, Drappatz J, et al. Response assess.ment challenges in clinical trials of gliomas [J]. Curr Oncol Rep, 2010, 12(1): 68-75.
-
5Lutz K, Radbruch A, Wiestler B, et al. Neuroradiological response criteria for high-grade gliomas [J]. Clin Neuro- mdiol, 2011, 21(4): 199-205.
-
6Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group [J]. J Clin Oncol, 2010, 28(11): 1963-1972.
-
7Vogelbaum MA, Jost S, Aghi MK, et al. Application of novel response/progression measures for surgically deliver- ed therapies for gliomas: Response Assessment in Neuro- Oncology (RANO) Working Group [J]. Neurosurgery, 2012, 70(1): 234-244.
-
8Clarke JL, Chang SM. Neuroimaging: diagnosis and response assessment in glioblastoma [J]. Cancer J, 2012, 18(1): 26- 31.
-
9Kruser TJ, Mehta MP, Robins HI. Pseudoprogression after glioma therapy: a comprehensive review [J]. Expert Rev Neurother, 2013, 13(4): 389-403.
-
10Pouleau HB, Sadeghi N, Baleriaux D, et ol. High levels of cellular proliferation predict pseudoprogression in glioblas- toma patients [J]. Int J Oncol, 2012, 40(4): 923-928.
引证文献7
-
1刘季平,王欣欣,刘俊,刘明,侯海东.CD133在不同病理级别脑胶质瘤中的表达及临床意义[J].现代医药卫生,2014,30(18):2756-2757.
-
2乜全民,郭品,郭烈美,李骁雄,葛建伟,邱永明.恶性胶质瘤治疗后影像学评估的研究进展[J].中国微侵袭神经外科杂志,2014,19(10):476-478. 被引量:3
-
3马光涛,张燕,李晨龙,郄福忠,曹振宇,蒋传路.姜黄素通过Wnt/β-catenin信号通路调控胶质瘤细胞增殖和凋亡的实验研究[J].中华神经外科杂志,2015,31(6):625-630. 被引量:7
-
4田少辉,许磊,李盼祥,赵瑜.老年胶质瘤患者肿瘤组织中CD105和血清可溶性CD105的表达及意义[J].中国医药,2016,11(8):1161-1164. 被引量:1
-
5李文斌,康勋,张红梅,陈建新,Wen Patrick Y,江涛.高级别胶质瘤的治疗反应评价标准[J].中华神经外科杂志,2017,33(3):304-307. 被引量:11
-
6马辉辉,张帆,杨林,王凡,孔令玲,权循凤,汪义纯,何雨祯.高级别胶质瘤术后放疗联合替莫唑胺治疗临床分析[J].中华肿瘤防治杂志,2017,24(18):1295-1300. 被引量:13
-
7耿亚东,孙德超,孔晨旭,丁炳谦,魏新亭,李振江.术后同步放化疗原发性胶质母细胞瘤患者预后影响因素分析[J].实用医学杂志,2021,37(18):2322-2325. 被引量:3
二级引证文献38
-
1张海明.替莫唑胺联合放疗治疗恶性脑胶质瘤的有效性[J].世界最新医学信息文摘,2020(38):128-128.
-
2王嘉嘉,梁军潮,伍犹梁,杜汉强,王伟民.伽玛刀联合替莫唑胺治疗脑转移瘤的假性进展1例[J].中国微侵袭神经外科杂志,2015,20(6):279-280. 被引量:6
-
3任义平,林海.低剂量分次放疗联合化疗治疗复发或进展恶性胶质瘤的疗效[J].医学临床研究,2015,32(7):1339-1341. 被引量:4
-
4张莉,邓守恒,陈萍,汤继英.姜黄素对宫颈癌Hela细胞株放疗增敏的机制研究[J].中国医师杂志,2015,17(11):1680-1681. 被引量:1
-
5刘瀚阳,薛宇洋,高凯,印竹胜,牛林军,顾玉明.shRNA干扰卷曲蛋白-7基因对HepG2肝癌细胞增殖和凋亡的影响[J].胃肠病学和肝病学杂志,2016,25(8):868-872.
-
6曾凡,王宽宇,胡慧敏,黄若愚,王永志,江涛.PDPN蛋白在脑胶质瘤中的表达及临床意义[J].中华神经外科杂志,2017,33(10):1057-1061. 被引量:3
-
7曾凡,姚坤,王宽宇,黄若愚,胡慧敏,王永志,江涛.FISH技术检测胶质瘤患者PTPRZ1-MET融合基因的表达及临床意义[J].中华神经外科杂志,2017,33(11):1160-1163. 被引量:2
-
8唐涛,马小翠,姚冰,陈一,张烨,孙佩欣,朴浩哲.未规律服用替莫唑胺对高级别胶质瘤辅助替莫唑胺同步放化疗效果影响[J].临床军医杂志,2018,46(2):211-212. 被引量:2
-
9惠小波,王彦平,李正明,王晓东,刘骥,刘岱.超声造影在判断脑胶质瘤术肿瘤残留的临床价值[J].现代医学,2018,46(2):149-152. 被引量:2
-
10张晶晶,杜鹏,逯霞,栾新平,木依提.阿不里米提.c-erbB-2与BCRP在脑胶质瘤中的表达及与临床分期的关系[J].标记免疫分析与临床,2018,25(8):1114-1116. 被引量:1
-
1王梓鹏,张金玲,刘白鹭.全脑CT灌注扫描在脑胶质瘤中的应用进展[J].医学影像学杂志,2014,24(11):2006-2009. 被引量:2
-
2朱明旺.神经影像进展[J].当代医学,2001,7(12):80-82.
-
3李文斌,康勋,张红梅,陈建新,Wen Patrick Y,江涛.高级别胶质瘤的治疗反应评价标准[J].中华神经外科杂志,2017,33(3):304-307. 被引量:11
-
4李林.^(18)F-FDGPET显像在肿瘤学中的应用[J].国外医学(放射医学核医学分册),2000,24(6):254-258. 被引量:1
-
5陈泽龙,赵春雷,杨忠东,钱根年,陈自谦.^(11)C-MET自动化合成及其在脑肿瘤显像中的应用价值[J].医疗卫生装备,2017,38(1):75-77. 被引量:1
-
6夏志,赵艳,尚画雨,张丹,苏全生,孙君志.衰老个体骨骼肌蛋白质代谢相关问题[J].中国老年学杂志,2016,36(14):3604-3607. 被引量:5